Bilanz

04.02.2018 • News

Strong results for DowDuPont in Q4

06.12.2013 • News

Consumer Health Division of Merck KGaA in Turnaround

05.11.2013 • News

Bayer Expects to Meet Earnings Forecast Despite Polymer Woes

30.10.2013 • News

Air Products Reports Solid Fourth Quarter and Fiscal 2013 Financial Results

28.10.2013 • News

BASF Chief Upholds 2013 Earnings Forecast After Strong Q3

16.05.2013 • News

Borealis Announces a Q1 Net Profit of €61 Million

14.05.2013 • News

Oxea Reports Strong EBITDA Uplift in Q1 2013

Adjusted EBITDA increased from €45 million in Q1 2012 to 53 million in Q1 2013 (+18%), the third best quarterly result of Oxea since its inception in 2007.

14.05.2013 • News

Momentive Specialty Chemicals Announces First Quarter 2013 Results

13.05.2013 • News

Prices, Royalties Concerns Cloud Israel Chemicals Profit

08.05.2013 • News

Brenntag Reinforces Position in Challenging Macroeconomic Environment

03.05.2013 • News

Gilead Profit Rises, But Sales of Older HIV Drugs Dip

02.05.2013 • News

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

01.05.2013 • News

Cheaper Crude Helps Phillips 66 Double Quarterly Profit

01.05.2013 • News

U.S. Launch of Novo's New Insulin Faces Long Delay

30.04.2013 • News

Strong Pet Product Sales Help Zoetis Top Estimates

30.04.2013 • News

Wacker Reports Steady Start to the New Fiscal Year in Q1 2013

30.04.2013 • News

Clariant Posts Growth in Q1 2013

27.04.2013 • News

Bayer Reports Successful 2012, Q1 2013

26.04.2013 • News

AbbVie Delivers on Scorching Humira Drug Sales Growth

26.04.2013 • News

Total Profit Falls on Lower Oil Prices, Output

26.04.2013 • News

Eastman Announces Q1 2013 Financial Results

26.04.2013 • News

BASF Beats Estimates with Crop Chemicals Lift

26.04.2013 • News

Potash Corp Drops Bid for Israel Chemicals

25.04.2013 • News

Biogen Profit Beats Estimates, Raises 2013 Forecast

25.04.2013 • News

Dow Chemical Sees Farm Products Driving Profit This Year

25.04.2013 • News

U.S. Oil Production Rises for Exxon, Conoco in Q1

25.04.2013 • News

AstraZeneca Q1 Sales Tumble as Generic Losses Bite Deep

25.04.2013 • News

Lonza Business Performance on Track

25.04.2013 • News

Thermo Fisher Profit up as Life Tech awaits

25.04.2013 • News

GSK Puts Lucozade and Ribena Drink Brands up for Sale

24.04.2013 • News

Novartis Seeks Productivity Improvements with New CFO

24.04.2013 • News

Sartorius Q1: on Course for Further Growth

24.04.2013 • News

Air Liquide Announces Q1 Results

24.04.2013 • News

Amgen First Quarter Sales Disappoint

51 more articles

Top-Feature

MOC – Event Center Messe München

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.